Market Value Added

(redirected from MVA)
Also found in: Medical, Acronyms, Wikipedia.

Market Value Added

The difference between the market value of an asset or company and the capital that shareholder or other investors have invested into it. A positive MVA means that the asset or company has increased in value while a negative MVA indicates the opposite. Obviously, an investor wants the highest MVA possible for his/her investments.
Mentioned in ?
References in periodicals archive ?
The KvistgENrd manufacturing plant, the world's only dedicated industrial manufacturing facility for MVA vaccines, began test-production in September.
In an ongoing Phase ll clinical study comparing different doses of the MVA nef vaccine with IMVAMUNE(TM), more than 50 of the planned 75 HIV-infected patients have been vaccinated.
Replacement of 220/132 KV 160MVA auto transformer with 250 MVA transformer at 500 KV Sheikh Mohammadi; replacement of two 220/132 KV 160 MVA auto transformers with 250 MVA transformer at 220 KV Bahawalpur Grid Station; replacement of four 220/132 KV 160 MVA auto transformer with 250MVA transformer at 220 KV Bund Road Grid Station Lahore and replacement of a 220/132kv 160MVA auto transformer with 250MVA transformer at 220 KV Ghazi Road Lahore.
SPTC Inaugurates Flagship 5000 MVA Capacity Power Transformer Manufacturing Plant in Saudi Arabia
In a standard MVA Epitope mapping protocol, three million antibody-captured peptides from the peptide display library will be analyzed and clustered.
MVA data further showed that crashes reduced by 20%, injuries reduced by 12% and fatalities increased by 62%.
Plus, they could end up receiving more money than they paid into the annuity if they cash surrender while the MVA is positive.
An MVA system takes process signals, such as melt pressure, screw position, barrel temperature, melt temperature, mold closing, filling, pack/hold, and cooling.
MVA is related to the more widely known Economic Value Added[TM] (EVA).
Acambis awarded second US Government MVA smallpox vaccine contract
The USPTO's patent grant to the MVA-BN[R] virus which is non-replicative in humans acknowledges the novelty and utility of such a virus exhibiting the demonstrated excellent safety profile of the MVA-BN[R] technology and other claimed MVA viruses exhibiting similar characteristics.
Disbursed across the state, these personnel will provide MVA branch offices with a broad range of hardware and software IT services supporting MVA's personal computers, network and cable systems, switches and related devices and software.